DIANE DAVENPORT WILDER M.D. NPI 1619959525

NPI Details

Diane Davenport Wilder, M.D. is a hematology and oncology internal medicine in Little Rock, AR with 30 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Diane Davenport Wilder, M.D. NPI is 1619959525. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: UNIVERSITY OF TEXAS MEDICAL SCHOOL AT SAN ANTONIO
Graduation Year:1996

The provider's business location address is:

8901 CARTI WAY
LITTLE ROCK, AR
ZIP 72205-523
Phone: (501) 219-8777
Fax: (501) 907-6522

The NPI 1619959525 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, azacitidine, 1 mg (HCPCS:J9025)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, atropine sulfate, 0.01 mg (HCPCS:J0461)
• Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg (HCPCS:Q5114)
• Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg (HCPCS:Q5107)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection, iron dextran, 50 mg (HCPCS:J1750)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron binding capacity (HCPCS:83550)
• Iron level (HCPCS:83540)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Magnesium level (HCPCS:83735)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Unclassified drugs (HCPCS:J3490)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Vitamin d-3 level (HCPCS:82306)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Cortisol (hormone) measurement, total (HCPCS:82533)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Nephelometry, test method using light (HCPCS:83883)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Protein measurement, serum (HCPCS:84165)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Folic acid level, serum (HCPCS:82746)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Automated urinalysis test (HCPCS:81003)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• Blood creatinine level (HCPCS:82565)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Thyroxine (thyroid chemical), total (HCPCS:84436)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Drawing of blood for a medical problem (HCPCS:99195)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Injection of drug or substance into vein (HCPCS:96374)

The enumeration date for this NPI number is 11/16/2005 and was last updated on 3/30/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.